Icon
+91 94997 68112
Login Register

Auvelity - (45 mg/105 mg; Tablet, Extended release)

Dextromethorphan Hydrobromide and Bupropion Hydrochloride Axsome Therapeutics
45 mg/105 mg; Tablet, Extended release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
None None
AUVELITY is a combination of dextromethorphan, an uncompetitive N-methyl D-aspartate (NMDA) receptor antagonist and sigma-1 receptor agonist, and bupropion, an aminoketone and CYP450 2D6 inhibitor, indicated for the treatment of major depressive disorder (MDD) in adults
Yes
****** ******** ******** ** ** ** *** **, ****.
Auvelity Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11 Patent 12 Patent 13 Patent 14 Patent 15 Patent 16 Patent 17 Patent 18 Patent 19 Patent 20 Patent 21 Patent 22 Patent 23 Patent 24 Patent 25 Patent 26 Patent 27 Patent 28 Patent 29 Patent 30 Patent 31 Patent 32 Patent 33 Patent 34 Patent 35 Patent 36 Patent 37 Patent 38 Patent 39 Patent 40 Patent 41 Patent 42 Patent 43 Patent 44 Patent 45 Patent 46 Patent 47 Patent 48 Patent 49 Patent 50 Patent 51 Patent 52 Patent 53 Patent 54 Patent 55 Patent 56 Patent 57 Patent 58 Patent 59 Patent 60 Patent 61 Patent 62 Patent 63 Patent 64 Patent 65 Patent 66 Patent 67 Patent 68 Patent 69 Patent 70 Patent 71 Patent 72 Patent 73 Patent 74 Patent 75 Patent 76 Patent 77 Patent 78 Patent 79 Patent 80 Patent 81 Patent 82 Patent 83 Patent 84 Patent 85 Patent 86 Patent 87 Patent 88 Patent 89 Patent 90 Patent 91 Patent 92 Patent 93 Patent 94 Patent 95 Patent 96 Patent 97 Patent 98 Patent 99 Patent 100 Patent 101 Patent 102 Patent 103 Patent 104 Patent 105 Patent 106 Patent 107
**** *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** *** ********* **** ** *** **, **** *** ********* *** ********* **** ** *** **, **** *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* *** ********* **** ** *** **, **** (***** ******) **** ** *** **, **** (***** ******) **** ** *** **, **** (***** ******) *** ********* (***** ******)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ********* *** **, **** ******* **** *** ****** *** ****
  1. *** **, **** : * ****-** ** ***** *** ***** ** *** *** *******.
  2. *** *, **** : **** ******** ****** ** ***** ****-** ****** **** ******* ’***, ’***, ’***, *** ’***.
  3. *** **, **** : ****** **** **** **** ************ ** ******* ’***, ’***, ’***, *** ’***, *** ******** ** *** **, ****
  4. *** **, **** : ****** **** **** **** ************ ** ***** ****** ******* ’****, '****, *** '****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.